s6y Altamira Therapeutics Ltd. 20-F

Altamira Therapeutics Ltd. 20-F, filed May 16, 2023: IDEA: XBRL DOCUMENT

Right-of-use assets and lease liabilities (Details) - Schedule of lease liabilities - CHF (SFr)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Schedule of Lease Liabilities [Abstract]    
As of January 1 SFr 575,736
thereof non-current 343,629 461,485
thereof current 117,856 114,251
Additions 594,436
Interest expense 15,949 3,000
Repayment of lease liability (130,200) (21,700)
As of December 31 SFr 461,485 SFr 575,736